Sr. Director, Clinical Development (MD) in San Francisco, CA

Save

compensation:

$200K - $250K

specialty:

Life Sciences

experience:

8 - 10 years

Job Description

Position Overview

The Sr. Director, Clinical Development (MD) will oversee the direction, planning, execution, and interpretation of clinical trials/research and the data collection activities.

Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems and final reports. May recruit clinical investigators and negotiates study design and costs. Responsible for directing human clinical trials, phases I IV for company products under development. Responsibilities also include adverse event reporting and safety responsibilities monitoring. Coordinates and develops reporting information for reports submitted to the FDA. Overall responsibility for adherence to protocols and determines study completion. May act as consultant/liaison with other corporations when working under licensing agreements. May select, develop, and evaluate personnel to ensure the efficient operation of the function.

Consistentl

See More

Valid through: 2020-1-20

About Nektar Therapeutics

Nektar Therapeutics (Nektar) (NASDAQ: NKTR) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the worlds first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. Exubera was also recognized as the most innovative diabetes medicine of 2006 in Germany. The company is engaged in developing a propriety pipeline of drug candidates for several therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. The companys research and development involve in small molecule and biologic drug candidates. Its drug candidate base consists of naloxegol (Movantik), a Phase III oral opioid antagonist, etirinotecan pegol, a topoisomerase inhibitor under Phase III clinical study as of 2012, NKTR 061, NKTR-181, NKTR-214, etc. In 2013, the company was assignment a patent which was developed by the company and other four co-inventors. The products of the company is served as a supplement to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability and other areas of drugs for the patients worldwide. As of March 2014, the company had an market capitalization of $1.7 billion with an enterprise value of $1.67 billion.
Total Jobs:
40
Average Pay:
$148,875
Total value of jobs:
$31,115,000
% Masters:
42%
Learn More About Nektar Therapeutics

More Jobs at Nektar Therapeutics

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Find similar Clinical Director jobs: